Logo image of ALF

CENTURION ACQUISITION CORP (ALF) Stock Fundamental Analysis

NASDAQ:ALF - Nasdaq - KYG203151009 - Common Stock - Currency: USD

10.5331  +0 (+0.03%)

Fundamental Rating

2

Overall ALF gets a fundamental rating of 2 out of 10. We evaluated ALF against 0 industry peers in the Unkown industry. ALF scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALF is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALF had positive earnings in the past year.
The reported net income has been mixed in the past 5 years: ALF reported negative net income in multiple years.
ALF had negative operating cash flow in 4 of the past 5 years.
ALF Yearly Net Income VS EBIT VS OCF VS FCFALF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

Industry RankSector Rank
ROA 3.6%
ROE 3.77%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALF Yearly ROA, ROE, ROICALF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2023 2024 0 -100 -200 -300

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ALF so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALF Yearly Profit, Operating, Gross MarginsALF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2023 2024 -20K -40K -60K

More info and screens

6

2. Health

2.1 Basic Checks

ALF has more shares outstanding than it did 5 years ago.
ALF has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALF Yearly Shares OutstandingALF Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2024 10M 20M 30M
ALF Yearly Total Debt VS Total AssetsALF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 16.37 indicates that ALF is not in any danger for bankruptcy at the moment.
ALF has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 16.37
ROIC/WACCN/A
WACCN/A
ALF Yearly LT Debt VS Equity VS FCFALF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2024 0 100M 200M

2.3 Liquidity

ALF has a Current Ratio of 5.29. This indicates that ALF is financially healthy and has no problem in meeting its short term obligations.
ALF has a Quick Ratio of 5.29. This indicates that ALF is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 5.29
Quick Ratio 5.29
ALF Yearly Current Assets VS Current LiabilitesALF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

ALF shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 123.83% yearly.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5Y123.83%
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALF Yearly Revenue VS EstimatesALF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 5K 10K 15K 20K 25K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALF is valuated quite expensively with a Price/Earnings ratio of 31.92.
ALF is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.03, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 31.92
Fwd PE N/A
ALF Price Earnings VS Forward Price EarningsALF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALF Per share dataALF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.26
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CENTURION ACQUISITION CORP

NASDAQ:ALF (8/6/2025, 10:06:26 AM)

10.5331

+0 (+0.03%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-14 2025-05-14
Earnings (Next)N/A N/A
Inst Owners105.16%
Inst Owner Change-68.7%
Ins OwnersN/A
Ins Owner Change-0.2%
Market Cap378.56M
Analysts0
Price TargetN/A
Short Float %0.01%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 31.92
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.32
P/tB 1.32
EV/EBITDA N/A
EPS(TTM)0.33
EY3.13%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS7.95
TBVpS7.95
PEG (NY)N/A
PEG (5Y)0.26
Profitability
Industry RankSector Rank
ROA 3.6%
ROE 3.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.29
Quick Ratio 5.29
Altman-Z 16.37
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5Y123.83%
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A